# CARBOXYMETHYLCELLULOSE SODIUM

URL: https://app.greenveil.ai/ingredients/ingredient_unii_k679_obs311
Categories: pharma
Identifier: cfr:21 CFR 173.310

> CARBOXYMETHYLCELLULOSE SODIUM. Route: BUCCAL; Dosage form: FILM; Maximum daily exposure: 18 mg Assessed from 48 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: Route: BUCCAL; Dosage form: FILM; Maximum daily exposure: 18 mg

## Regulatory status

- US: inactive ingredient database — Route: BUCCAL; Dosage form: FILM; Maximum daily exposure: 18 mg
- US: inactive ingredient database — Route: BUCCAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 47 mg
- US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Potency: 4 mg
- US: inactive ingredient database — Route: DENTAL; Dosage form: GEL; Potency: 0.4 %w/w
- US: inactive ingredient database — Route: DENTAL; Dosage form: PASTE; Maximum daily exposure: 249 mg
- US: inactive ingredient database — Route: DENTAL; Dosage form: PASTE, DENTIFRICE; Potency: 1.2 %w/w
- US: inactive ingredient database — Route: ENTERAL; Dosage form: SUSPENSION; Maximum daily exposure: 2920 mg
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION; Maximum daily exposure: 25 mg
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Maximum daily exposure: 25 mg
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 30 mg
- US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 15 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 30 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Maximum daily exposure: 25 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 5 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 30 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: POWDER, FOR SUSPENSION; Potency: 0.7 %w/v
- US: inactive ingredient database — Route: INTRASYNOVIAL; Dosage form: INJECTION; Potency: 0.1 %w/v
- US: inactive ingredient database — Route: INTRAVITREAL; Dosage form: INJECTION, SUSPENSION; Potency: 0.5 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Potency: 160 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Potency: 4.2 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 4 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Potency: 15.63 mg/5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Maximum daily exposure: 161 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 560 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 3480 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 1600 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION/ DROPS; Potency: 12.85 mg/2.5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Potency: 26.5 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 280 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: 24.75 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 3.2 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 280 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 933 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 50 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 100 mg
- US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION; Potency: 0.75 %w/v
- US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 15 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Potency: NA
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Potency: NA
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 1680 mg
- US: inactive ingredient database — Route: VAGINAL; Dosage form: AEROSOL, FOAM; Potency: 0.2 %w/w
- US: inactive ingredient database — Route: VAGINAL; Dosage form: CREAM; Potency: 0.75 %w/w
- US: marketed drug occurrence — FDA NDC lists this ingredient in 67 active drug products and 67 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as mixture.

_Assessed by Greenveil._